Growth factors in wound healing: the present and the future?

Thanh Dinh1, Shawn Braunagel2, Barry I Rosenblum1

  • 1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Insights

Advanced delivery systems show promise for chronic wound healing by overcoming limitations of single growth factor treatments. Biomimetic approaches using tissue engineering can improve growth factor efficacy.

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Wound Healing Research

Background:

  • Growth factors are crucial for wound healing, but their levels are often reduced in chronic wounds.
  • Traditional single growth factor treatments have shown limited success due to short half-life and poor delivery.
  • The chronic wound environment, characterized by protease activity, further hinders growth factor effectiveness.

Purpose of the Study:

  • To explore advanced delivery systems for growth factors in chronic wound treatment.
  • To investigate the potential of biomimetic delivery strategies in enhancing growth factor efficacy.
  • To overcome the limitations of traditional bolus dosing for growth factor therapy.

Main Methods:

  • Utilizing advances in tissue engineering and regenerative medicine for growth factor delivery.
  • Employing polymer systems, scaffolds, and hydrogels for spatially oriented, multi-growth factor delivery.
  • Developing biomimetic approaches to mimic natural healing processes.

Main Results:

  • Improved tissue response observed when growth factors are delivered using advanced biomimetic systems.
  • Potential for accelerated healing in chronic wounds through enhanced delivery mechanisms.
  • Overcoming challenges associated with growth factor degradation and suboptimal dosing.

Conclusions:

  • Advanced delivery systems, including scaffolds and hydrogels, offer a promising strategy for chronic wound healing.
  • Biomimetic delivery of multiple growth factors can significantly improve therapeutic outcomes.
  • Tissue engineering innovations are key to realizing the full potential of growth factor therapy for complex wounds.

Related Concept Videos

Phases of Wound Repair01:28

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
10.0K
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
3
Overview of Regeneration and Repair01:19

Overview of Regeneration and Repair

Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
6.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.5K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
9.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K